Use of intravitreal dexamethasone implant associated or not with antiVEGF therapy in diabetic macular edema: efficacy and safety
Introduction: Diabetic macular edema (DME) is characterized by macular exudation and damage to retinal microvasculature. It is estimated that 30% of diabetic patients develop DME during the course of the disease. Currently, Anti–vascular endothelial growth factor therapy (Anti-VEGF) is first-lin...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Associação Médica de Minas Gerais
2026-03-01
|
| Serie: | Revista Médica de Minas Gerais |
| Soggetti: | |
| Accesso online: | https://rmmg.org/artigo/detalhes/4207 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|